บุคลากรสายวิชาการ

รศ.ดร.ภญ. จิระพรรณ จิตติคุณ รศ.ดร.ภญ. จิระพรรณ จิตติคุณ jiraphun.jit@mahidol.ac.th jiraphun.jit@mahidol.ac.th อาจารย์ประจำภาควิชาชีวเคมี , รักษาการแทนรองคณบดีฝ่ายบริหาร

2021

1. A systematic review and meta-analysis of genotype-based and individualized data analysis of SLCO1B1 gene and statin-induced myopathy

   Turongkaravee S, Jittikoon J*, Lukkunaprasit T, Sangroongruangsri S, Chaikledkaew U, Thakkinstian A. Pharmacogenomics J 2021; 21(3): 296-307.
   
   

2. Cartilage oligomeric matrix protein as a marker of progressive liver fibrosis in biliary atresia

   Udomsinprasert W*, Angkathunyakul N, Jittikoon J, Chaikledkaew U, Vejchapipat P, Poovorawan Y, Honsawek S. Scientific Reports 2021; 11(1): 16695.
   
   

3. Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases

   Udomsinprasert W*, Sobhonslidsuk A, Jittikoon J, Honsawek S, Chaikledkaew U. Expert Opinion on Therapeutic Targets 2021; 25(9): 799-813.
   
   

4. Circulating levels of interleukin-6 and interleukin-10, but not tumor necrosis factor-alpha, as potential biomarkers of severity and mortality for COVID-19: systematic review with meta-analysis

   Udomsinprasert W*, Jittikoon J, Sangroongruangsri S, Chaikledkaew U. Journal of clinical immunology 2021; 41(1): 11-22.
   
   

5. Clusterin is associated with systemic and synovial inflammation in knee osteoarthritis

   Ungsudechachai T, Honsawek S, Jittikoon J, Udomsinprasert W*. Cartilage 2021; 13: 1 : 1557S-1565S.
   
   

6. CYP2E1, GSTM1, and GSTT1 genetic polymorphisms and their associations with susceptibility to antituberculosis drug-induced liver injury in Thai tuberculosis patients

   Chanhom N, Wattanapokayakit S, Satproedprai N, Suvichapanich S, Mahasirimongkol S, Chaikledkaew U, Udomsinprasert W, Mushiroda T, Jittikoon J*. Heliyon 2021; 7(4): e06852.
   
   

7. Diagnostic value of interleukin-34 as a novel biomarker for severity of knee osteoarthritis

   Udomsinprasert W*, Panon K, Preechanukul S, Jittikoon J, Jinawath A, Honsawek S. Cartilage 2021; 13(2_suppl): 1174S-1184S.
   
   

8. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury

   Udomsinprasert W*, Sakuntasri W, Jittikoon J, Chaikledkaew U, Honsawek S, Chantratita W, Wattanapokayakit S, Mahasirimongkol S. Emerging Microbes and Infections 2021; 10(1): 1862-1872.
   
   

9. HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Filipino patients

   Capule F, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Alentajan-Aleta LT, Barit J-VJ, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Silao CL. Pharmacogenomics 2021; 22(8): 465-472.
   
   

10. Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

    Turongkaravee S, Jittikoon J, Rochanathimoke O, Boyd K, Wu O, Chaikledkaew U*. BMC Health Services Research 2021; 21(1): 1042.
    
    

2020

1. Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients.

   Capule F*, Tragulpiankit P, Mahasirimongkol S, Jittikoon J, Wichukchinda N, Theresa Alentajan-Aleta L, James Barit JV, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Salonga R, San Gabriel KF, Lynn Silao C. Pharmacogenomics journal 2020; 20(3): 533-541.
   
   

2. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis

   Udomsinprasert W*, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Journal of infection 2020; 81(4): 585-599.
   
   

3. Economic impact of medical genetic testing on clinical applications in Thailand

   Jittikoon J, Sangroongruangsri S, Thavorncharoensap M, Chitpim N, Chaikledkaew U*. PLoS one 2020; 15(12): e0243934.
   
   

4. GSTM1 and GSTT1 genetic polymorphisms and their association with antituberculosis drug-induced liver injury

   Chanhom N, Udomsinprasert W, Chaikledkaew U, Mahasirimongkol S, Wattanapokayakit S, Jittikoon J*. Biomedical reports 2020; 12(4): 153-162.
   
   

5. Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury

   Udomsinprasert W, Chanhom N, Suvichapanich S, Wattanapokayakit S, Mahasirimongkol S, Chantratita W, Jittikoon J*. Scientific reports 2020; 10(1): 5628.
   
   

2019

1. Interleukin-34 as a promising clinical biomarker and therapeutic target for inflammatory arthritis

   Udomsinprasert W*, Jittikoon J, Honsawek S. Cytokine and Growth Factor Reviews -
   
   

2. Leukocyte mitochondrial DNA copy number as a potential biomarker indicating poor outcome in biliary atresia and its association with oxidative DNA damage and telomere length

   Udomsinprasert W, Poovorawan Y, Chongsrisawat V, Vejchapipat P, Jittikoon J, Honsawek S*. Mitochondrion 2019;47:1-9
   
   

3. Publication Preview Source Southeast Asian Pharmacogenomics Research Network (SEAPharm): Current Status and Perspectives

   Chumnumwat S, Lu Z, H, Sukasem C, Winther M, D, Capule F, R, Abdul Hamid A, A, Bhandari B, Chaikledkaew U, Chanhom N, Chantarangsu S, Charoenyingwattana A, Hang T, T, Hlaing T, M, Htun K, S, Jittikoon J, Le L, Mahasirimongkol S, Mohamed Noor D, A, Sh Public Health Genomics
   
   

4. Vitamin D and liver fibrosis: Molecular mechanisms and clinical studies

   Udomsinprasert W, Jittikoon J*. Biomedicine and Pharmacotherapy 2019; 109: 1351-1360.
   
   

2018

1. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype

   Capule F, Tragulpiankit P, Mahasirimongkol S, Wichukchinda N, Jittikoon J, Alentajan-Aleta LT, Jay-V James Barit, Casanova-Gutierrez J, Cabral-Lim L, Baltazar Reyes JP, Roa F, Katrina Faith San Gabriel, Catherine Lynn Silao. BMJ Case Reports 2018 (Article in Press)
   
   

2. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: A genotype-based meta-analysis

   Suvichapanich S, Fukunaga K, Zahroh H, Mushiroda T, Mahasirimongkol S*, Toyo-Oka L, Chaikledkaew U, Jittikoon J, Yuliwulandari R, Yanai H, Wattanapokayakit S, Tokunaga K. Pharmacogenetics and Genomics 2018; 28(7): 167-176
   
   

3. Topoisomerase I inhibitory activity and 3D QSAR studies of chromone derivatives.

   Maicheen C, Phosrithong N, Jittikoon J, Ungwitayatorn J.* Chiang Mai Journal of Science 2018; 45(2): 1073-1086
   
   

2016

1. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations

   Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y.f, Mcleod H.L.f, Chantratita W*. Journal of Human Genetics. 2016; 61(2): 119-127.
   
   

2015

1. Association analysis of CYP2C9∗3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children

   Suvichapanich S, Jittikoon J, Wichukchinda N, Kamchaisatian W, Visudtibhan A, Benjapopitak S, Nakornchai S, Manuyakorn W*, Mahasirimongkol S Journal of Human Genetics 2015; 60(8): 413-417
   
   

2. Comparison of genetic variation in drug ADME-related genes in Thais with Caucasian, African and Asian HapMap populations.

   Jittikoon J, Mahasirimongkol S, Charoenyingwattana A, Chaikledkaew U, Tragulpiankit P, Mangmool S, Inunchot W, Somboonyosdes C, Wichukchinda N, Sawanpanyalert P, He Y, McLeod HL, Chantratita W*. Journal of Human Genetics 2015; 1-9
   
   

3. Effect of N-terminal truncation on antibacterial activity, cytotoxicity and membrane perturbation activity of Cc-CATH3

   Jittikoon J*, Ngamsaithong N, Pimthon J, Vajragupta O. Archives of Pharmacal Research 2015; 38(10): 1839-1849
   
   

4. Short native α-helical cationic antimicrobial peptides: promising alternative antibiotics.

   Jittikoon J*. The Thai Journal of Pharmaceutical sciences 2015; 39(1): 1-9.
   
   

2013

1. Synthesis, Topoisomerase I Inhibitory and Cytotoxic Activities of Chromone Derivatives

   Maicheen C, Jittikoon J, Vajragupta O, Ungwitayatorn J*. Medicinal Chemistry 2013; 9(3): 329-339
   
   

2012

1. Antibacterial Activity of Cc-CATH3 Peptide and its N-terminally Truncated Analogues against Gram-positive and Gram-negative Bacteria.

   Ngamsaithong N, Pimthon J, Vajragupta O, Jittikoon J*. Mahidol University Journal of Pharmaceutical Sciences 2012; 39(2): 1-6
   
   

2. Molecular Dynamics and Experimental Investigations of Membrane Perturbation by Ceragenin CSA-13

   Jueati R, Jittikoon J, Vajragupta O, Pimthon J*. Mahidol University Journal of Pharmaceutical Sciences 2012; 40(2): 25-32
   
   

2011

1. Protective Effect of Natural Protein Fractions from Cajanus Cajan (L.) on H2O2-Treated Human TK6 Cells.

   Klungsupya P, Muangman T, Leelamanit W, Jittikoon J, Martwanna C. Thai Journal of Pharmaceutical Sciences 2008; 35(Suppl.): 12-13
   
   

2008

1. Thin Layer Chromatography-Bioautography for Detection of Antibiotics

   Saeher V, Yawyuan P, Jittikoon J, Leelamanit W. Thai J. Pharm. Sci. 2008; 32 (Suppl.)
   
   

---

หมายเหตุ: ชื่อที่ใช้ในการทำวิจัยของ รศ.ดร.ภญ. จิระพรรณ จิตติคุณ ได้แก่ จิระพรรณ จิตติคุณ ; Jittikoon J ;